News
The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...
Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...
NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...
The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.
The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...
Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...
MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services
The agreement has been designed to offer a turnkey service to companies seeking faster time to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results